Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - AMERICAN CRYOSTEM Corp | ex31_2.htm |
| EX-31.1 - EXHIBIT 31.1 - AMERICAN CRYOSTEM Corp | ex31_1.htm |
| 10-Q - FORM 10-Q - AMERICAN CRYOSTEM Corp | acryo_2q20.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002
In connection with this Quarterly Report of American CryoStem Corporation (the “Company”), on Form 10-Q for the three months ended March 31, 2020,as filed with the U.S. Securities and Exchange Commission on the date hereof, I, John Arnone, Chief Executive Officer of the registrant and Anthony Dudzinski, Principal Financial Officer of the registrant, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | Such Quarterly Report on Form 10-Q for the three months ended March 31, 2020 fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in such Quarterly Report on Form 10-Q for the three months ended March 31, 2020 fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| May 20, 2020 | By: | /s/ John Arnone | |
| John Arnone | |||
Chief Executive Officer American CryoStem Corporation |
|||
| May 20, 2020 | By: | /s/ Anthony Dudzinski | |
| Anthony Dudzinski | |||
Chief Principal Officer American CryoStem Corporation |
| 40 |